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Nerve root avulsion in brachial plexus injuries is a relatively 
common occurrence, and few strategies exist to promote nerve 
root regeneration back into the spinal cord.1-3 Previous work 
in our lab revealed that hydrogels of thiolated chondroitin 
sulfate-C (CS-C) crosslinked with poly(ethylene glycol)- 
diacrylate (PEG-DA) could support robust growth of nerve roots 
in vitro,4,5 but, CS-C is inhibitory to central neurons,6 which 
may pose a problem in reintegrating the central and peripheral 
nervous systems in nerve root avulsion repair. However, previous 
work also revealed that addition of a peptide with the sequence 
EKR IWF PYR RF (EKR) to cultures of primary cortical neu-
rons increased neurite outgrowth on CS-C-coated surfaces by 
binding with CS-C chains to block their inhibitory activity.6 
Unpublished work in our lab also suggests that this peptide 
binds with nerve growth factor (NGF) when it is incorporated 
into CS hydrogels, as release studies with NGF showed slower 
release of NGF from CS matrices when this peptide was incor-
porated. Therefore, in light of the robust growth of dorsal root 
ganglion (DRG) neurites cultured in CS gels already observed,4 
it is hypothesized that addition of this peptide may enhance 
neural growth by sequestering NGF and increasing its bioavail-
ability. In addition, it is possible that this peptide may also 
block any potential inhibition from the CS glycosaminoglycan 
(GAG). Furthermore, incorporation of this peptide may help in 
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encouraging central neurons to regenerate into the matrix by 
blocking central inhibition of CS-C.
The goals of this study were to characterize the impact of 
incorporation of EKR peptide on hydrogel physical and mechan-
ical properties, to determine its influence on NGF release from 
these matrices, and to observe the effect this peptide has on DRG 
neurite outgrowth. Mechanical properties of peptide-containing 
hydrogels were measured using rheology, and hydrogel pore sizes 
were analyzed using cryo-scanning electron microscopy (SEM). 
NGF diffusivity from these matrices was determined using a 
fluorescence recovery after photobleaching (FRAP) technique. 
Finally, DRGs were cultured in these hydrogels, and neurite 
lengths and growth rates were measured to investigate the impact 
of peptide incorporation on neural growth. A second study, 
reported separately, shows that the peptide also helps to encour-
age cortical neurite growth in CS gels.
Addition of peptide in these experiments did not have any 
effect on the linear viscoelastic region for either gel. In addition, 
the G' values only exhibited statistically significant reduction at 
a few stresses and frequencies when peptide was added to either 
hydrogel (Figs. 1 and 2). The data for control gels of CS and 
hyaluronic acid (HA) are from previous work.4
Exemplar cryo-SEM images are shown of each hydrogel con-
taining 0 or 76.9 nM EKR peptide in Figures 3 and 4. Average 
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of peptide up to 1:100 molar excess (corresponding to 76.9 nM 
EKR) to NGF showed no significant differences in neurite length 
or growth rate (Fig. 7). However, when peptide was added to 
CS gels, significant increases in growth rates over controls were 
observed for all three peptide treatments, but increased neu-
rite length was observed for the 1:100 peptide treatment only 
(Fig. 8). In addition, DRGs cultured in gels containing pep-
tide were viable for an additional day longer than those grown 
in control gels. Of the three peptide concentrations investi-
gated, the highest (1:100) exhibited the greatest amount of sig-
nificant increases in neurite length and growth rate over control 
gels.
In a final trial, neurite lengths were measured in gels of 2% 
HA containing no peptide, 2% CS containing no peptide and 
2% CS containing a 1:100 molar ratio of NGF to peptide. 
Representative images of DRGs cultured in this final study are 
shown in Figures 9–11. Figure 12 shows that CS gels containing 
a 1:100 NGF-to-peptide ratio exhibited an increase in neurite 
length over both control gels on days 3 and 4. Neurites of DRGs 
showed breakdown by day 4 in HA gels, but those in both CS 
gels continued to grow for one more day.
pore sizes were 26.5 μm2 in 2% CS containing 76.9 nM EKR 
peptide and 20.6 μm2 in 2% HA containing 76.9 nM EKR 
peptide. Assuming circular pores, these areas correspond to pore 
diameters of 5.8 and 5.1 μm, respectively. When compared with 
the pore sizes of gels without peptide obtained previously in refer-
ence 4, we see that addition of the peptide significantly reduced 
the pore sizes of both of the gels (Fig. 5). It is interesting to note 
that the degree of reduction was greater for HA gels than for CS 
gels, as addition of peptide to HA gels resulted in pore sizes simi-
lar to CS gels with peptide.
The measured diffusivity coefficients for each hydrogel treat-
ment are compared in Figure 6. Diffusivity coefficients were 
approximately 6.1 x 10-13 m2/s in 2% CS, 4.3 x 10-13 m2/s in 
2% CS containing 76.9 nM EKR peptide, and 2.4 x 10-13 m2/s 
in both 2% HA and 2% HA containing 76.9 nM EKR pep-
tide. The addition of the EKR peptide significantly decreased the 
mobility of NGF in 2% CS gels, while it had no effect when 
added to 2% HA gels.
Analysis of DRG images revealed significant increases in neu-
rite growth over controls in CS gels only. In HA gels, addition 
Figure 1. Storage moduli of 2% CS hydrogels containing either 0 or 
76.9 nm EKr peptide (n = 3). (a) Stress sweeps, using 10 hz frequency, 
(B) frequency sweeps, using 100 Pa shear stress (error bars ± standard 
deviation, *p ≤ 0.05 for the specific stress).
Figure 2. Storage moduli of 2% ha hydrogels containing either 0 or 
76.9 nm EKr peptide (n = 3). (a) Stress sweeps, using 10 hz frequency, 
(B) frequency sweeps, using 100 Pa shear stress (error bars ± standard 
deviation, *p ≤ 0.05 for the specific frequency).
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greatly change the mechanical properties of either 2% CS or 2% 
HA, as revealed by rheological studies.
In scaffolds composed of collagen and GAGs, cell attachment 
can increase with smaller pore size because of the increased sur-
face areas these matrices provide.7 It is therefore possible that the 
smaller pore sizes resulting from addition of peptide was partially 
responsible for the increase in DRG neurite outgrowth observed. 
However, it is unlikely that this was the sole reason, since we saw 
increased growth in hydrogels of 2% CS + EKR peptide only, 
while addition of peptide to 2% HA did not increase outgrowth, 
despite the similar pore sizes of these two scaffolds. In addition, 
it is likely that there is a limit to the growth-promoting effect 
of increasing scaffold surface area, since pores must be large 
Addition of EKR peptide at a concentration of 76.9 nM 
showed a significant reduction in the G' of both hydrogels at only 
a few stresses and frequencies. These small differences were likely 
the result of fewer crosslinks formed between CS and PEG in 
these gels, since the peptide was occupying some of the acrylate 
groups on PEG molecules. Overall, the addition of this amount 
of peptide has a negligible effect on the mechanical properties of 
the hydrogels.
Pore analysis previously revealed statistical differences 
between 2% CS and 2% HA control gels,4 and here it can be 
seen that addition of the peptide at 76.9 nM concentration sig-
nificantly reduced these pore sizes. It is important to note that 
the smaller pore sizes caused by addition of EKR peptide did not 
Figure 3. representative cryo-SEm images of 2% CS hydrogels. (a) 1,000x, with no peptide; (B) 20,000x, with no peptide; (C) 1,000x, with 76.9 nm EKr 
peptide; (D) 20,000x, with 76.9 nm EKr peptide.
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and r is the pore radius of the matrix. The first squared term 
in this expression, the partition coefficient, is an expression 
modeling the increase in steric forces or the reduction in con-
centration of solute at the mouth of the pore as compared with 
that in bulk solution. In our FRAP studies, NGF was already 
present in the matrices, so this value reduces to 1, simplifying 
equation 1 to
  
(1)
In our calculations, the hydrodynamic radius of NGF was cal-
culated using the expression:8
enough to allow cells to migrate through them.7 It appears that 
the smaller pore sizes in gels containing peptide did not reach this 
limit, since decreased growth was not observed when peptide was 
added in either hydrogel.
To test the reasonableness of the diffusion coefficients 
obtained, we calculated theoretical D values for NGF in each of 
the gels using the Renkin equation:8
where D
m
 is the solute pore diffusivity, D is the solute’s bulk 
diffusivity in solution, a is the solute hydrodynamic radius, 
Figure 4. representative cryo-SEm images of 2% ha hydrogels. (a) 1,000x, with no peptide; (B) 20,000x, with no peptide; (C) 1,000x, with 76.9 nm EKr 
peptide; (D) 20,000x, with 76.9 nm EKr peptide.
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where MW is the molecular weight of NGF, 
and N
A
 is Avogadro’s number. This expression 
assumes that the solute of molecular weight 
MW is a sphere with a density ρ, which is equal 
to the density of the solute in the solid phase (in 
this case, ρ = 1 g/cm-3). The value for D in equa-
tion 2 was calculated using the Stokes-Einstein 
expression:8
   
(2)
where R is the ideal gas constant, T is the 
temperature of the system in Kelvin, N
A
 is 
Avogadro’s number, and μ is the solution vis-
cosity. The pore sizes calculated for each of the 
matrices using cryo-SEM images were used for r 
values in equation 2.
Owing to the large sizes of the pores com-
pared with the theoretical hydrodynamic radius 
of the NGF protein, the theoretical diffusivity 
of NGF in each of these matrices was almost 
identical to that in solution. We calculated 
D values of 9.85 x 10-11 for both CS and HA 
matrices, regardless of the presence of peptide. 
It should be noted that the model used assumes 
perfectly straight pores and no interaction of 
NGF with the matrix, both of which are not 
applicable to our gels, as cryo-SEM images 
revealed significant tortuosity in the channels, 
and capillary electrophoresis previously revealed 
binding activity between NGF and both CS and 
HA.4 Therefore, one would expect the experi-
mental diffusion coefficient for these matrices 
to be lower than this calculated value, which is 
what we observed.
We also wanted to know whether these D val-
ues correlated with known diffusivity values of 
neurotrophic factors in neural tissue, in order to 
determine the applicability of these gels to a sys-
tem in vivo. Stroh et al. measured the diffusivity 
of rhodamine-labeled 2.5S NGF injected into 
coronal slices of the rat brain striatum using a 
multiphoton microscopy technique. They deter-
mined the D value for NGF in the rat brain to be 
2.75 x 10-11 m2/s, which is higher than the D val-
ues we obtained for our gels, which were on the 
order of 10-13 m2/s. This difference can be attrib-
uted to the differences in composition of brain 
tissue and our hydrogel matrices. Although 
pores in brain tissue have an estimated width of 
Figure 5. Cryo-SEm pore size analysis (error bars ± standard error of the mean, *denotes 
statistical insignificance).
Figure 6. Comparison of measured hydrogel diffusion coefficients for FitC-NGF (error bars 
± standard deviation, *denotes statistical insignificance, n = 11 for 2% CS, 12 for 2% CS + 
EKr, 10 for 2% ha and 14 for 2% ha + EKr). two gels for each treatment were measured, 
each contributing several datapoints.
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not in HA, despite the similar pore sizes of these two peptide-
containing matrices. This would seem to indicate that the bind-
ing activity of the peptide is dependent on the presence of CS. 
Indeed, in other unpublished studies in our lab with this peptide 
sequence, slowed release of NGF was observed when the peptide 
was incorporated into hydrogels of CS-C. Synergistic activity 
between CS-C and the peptide was also observed; as PEG gels 
containing both of these components showed statistical differ-
ences in NGF release when compared with control gels contain-
ing neither, while PEG gels containing either CS-C or peptide 
did not. It is possible that this peptide’s synergistic effect on NGF 
binding is exclusive to CS, but additional characterization will 
need to be undertaken to determine the mechanisms involved in 
this phenomenon in order to ascertain this. HA is an unsulfated 
GAG, so sulfation may be a requirement for a GAG to exhibit 
this synergistic binding activity. It is possible that other CS vari-
ants, or even other sulfated GAGs, such as heparan sulfate and 
keratan sulfate, could have the same effect with this peptide. It is 
Figure 7. ha gel DrG culture analysis. No statistical differences were 
observed; n = 14 for 100:1 EKr:NGF, and 16 for all other treatments.  
(a) measured neurite length over time in 2% ha gels. (B) Growth rates 
of neurites, calculated by subtracting the neurite length of the previous 
day from the length of the current day.
Figure 8. CS gel DrG culture analysis. Error bars ± standard error of 
the mean; n = 5 for 100:1 and 1:1 EKr:NGF, and 7 for 10:1 EKr:NGF and 
control. (a) measured neurite length over time in 2% CS gels (*p ≤ 0.05 
for control vs. 100:1 peptide treatment). (B) Growth rates of neurites, 
calculated by subtracting the neurite length of the previous day from 
the length of the current day (*p ≤ 0.05).
only 38–64 nm,10 GAGs make up less than 0.1% of its total dry 
weight.11 By contrast, the GAGs in our hydrogels constituted over 
50% of the total dry weight, so our gels contain orders of magni-
tude more binding sites for NGF, resulting in much slower diffu-
sion. This lower diffusivity could be a good sign for our material, 
as it may indicate that, if the hydrogel were loaded with NGF and 
implanted into neural tissue, it could sequester NGF for longer 
than if NGF were merely administered alone. This sequestering 
activity could serve to protect NGF from proteolytic degradation, 
and increase its half-life and efficacy in vivo.
The results in the FRAP studies correlate well with the bind-
ing constant data of CS and HA with NGF obtained in previ-
ous capillary electrophoresis studies. When investigating binding 
strength with NGF, we obtained K
d
 values of 34 μM for CS and 
25 μM for HA.4 Since HA binds NGF slightly more strongly than 
CS, it was expected that the diffusivity of NGF would be lower in 
matrices of HA than it would be in a similar matrix of CS.
A very interesting phenomenon in this study was that addition 
of the EKR peptide reduced diffusion of NGF in CS gels, but 
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were observed in peptide-treated and control HA gels, showing 
that the peptide had no effect.
It was previously demonstrated that CS-C inhibited neurite 
growth in primary cortical neurons in a 2-D culture model, and 
this peptide was originally developed to bind with CS to block 
its inhibitory activity.6 Although in the current study the pep-
tide was immobilized in the matrix, it should be noted that it 
is possible that this peptide bound with CS and blocked any 
inhibitory signals that it may have presented, and this could have 
contributed to some of the increases in neurite growth observed 
in peptide-containing CS gels. However, as noted in previous 
work in references 4 and 12, CS-C shows little to no inhibi-
tion of growth in whole DRG cultures, so this would likely be a 
minor factor.
It was necessary to compare neurite outgrowth in peptide-
enhanced CS matrices with that in HA gels to definitively dem-
onstrate that this system produces better growth than HA gels. 
Of the peptide concentrations examined, the 1:100 treatment 
showed the most significant increases in growth over controls, 
so it was used for comparison with HA. The peptide did not 
enhance growth in HA, therefore, only HA matrices were used 
as controls. In our final trial, we again saw increases in neurite 
growth in peptide-treated CS gels over both control CS gels and 
HA gels. We also saw that CS gels were able to support DRG 
growth for longer than HA gels, with both peptide-treated and 
control CS supporting DRG viability for one more day than 
HA. Taken together, these data indicate that peptide-treated CS 
gels can better support neurite outgrowth than both untreated 
CS and HA gels.
also possible that this synergy is exclusive to CS-C, if the unique 
combination of polysaccharide structure and sulfation patterns 
it presents is a requirement for synergistic NGF-binding activity.
It was previously discovered that hydrogels of CS supported 
DRG neurite outgrowth better than hydrogels of HA did, pos-
sibly due to inhibitory signals presented by HA.4 We asked if 
it would be possible to enhance the growth we observed in CS 
gels by incorporating an NGF-binding peptide into the matrix. 
In order to find an appropriate amount of peptide to add to the 
gel, multiple concentrations were tested, which corresponded to 
1, 10 and 100 times the concentration of NGF present in the 
gels. This served to test the concentration of peptide necessary 
to adequately sequester NGF in the matrix to produce increased 
neurite growth. As anticipated, addition of peptide increased 
neurite growth over controls in CS gels, but not in HA gels. 
Indeed, no statistical differences in neurite length or growth rate 
were observed in any of our peptide-containing HA treatments 
when compared with control gels.
This is an interesting phenomenon that agrees with the NGF 
diffusivity results obtained in FRAP studies, where there was no 
observable change in NGF mobility when 76.9 nM peptide (cor-
responding to the 1:100 treatment in DRG studies) was incor-
porated into the gels, but decreased mobility was observed when 
the peptide was added to CS gels. Taken together, these data 
suggest that the peptide helped better sequester NGF into CS 
matrices, making it more available to neurons and resulting in 
improved neurite outgrowth. Because the peptide does not bind 
NGF when incorporated into HA gels, similar degrees of growth 
Figure 9. representative phase contrast images of DrGs cultured in CS 
hydrogels containing 100:1 EKr:NGF in the final culture study (scalebar 
= 0.25 mm). arcs denote the approximate neurite length in each im-
age (a) CS, 100:1 EKr:NGF, 1 d; (B) CS, 100:1 EKr:NGF, 2 d; (C) CS, 100:1 
EKr:NGF, 3 d; (D) CS, 100:1 EKr:NGF, 4 d.
Figure 10. representative phase contrast images of DrGs cultured in 
control CS hydrogels in the final culture study (scalebar = 0.25 mm). 
arcs denote the approximate neurite length in each image (a) CS con-
trol, 1 d; (B) CS control, 2 d; (C) CS control, 3 d; (D) CS control, 4 d.
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or HA was added to the solution to form hydrogels, as described 
previously in reference 5.
For hydrogel rheological characterization, 2% hydrogels of CS 
or HA, crosslinked with PEG-DA, were prepared as described 
previously in reference 5, with the exception that they were 
made containing 76.9 nM EKR peptide. Viscoelastic responses 
were determined using stress and frequency sweeps as described 
previously in reference 4, utilizing an AR-G2 rheometer (TA 
Instruments) and a parallel plate geometry with a 20-mm diam-
eter and a 585-μm gap. 30 min time sweeps at 0.5 Pa and 1 
Hz were executed during gelation to ensure the sample had fully 
gelled before further testing was run. All tests were run in tripli-
cate, and statistical analysis of rheological data was accomplished 
using ANOVA (α = 0.05) in Origin Pro 8.0 (OriginLab).
For cryo-SEM characterization, gel samples of 2% CS and 2% 
HA containing 76.9 nM EKR peptide were made in specialized 
slit holders. Imaging methods were identical to those described 
previously in reference 4, using an FEI NOVA nanoSEM field 
emission SEM (FEI Company). Images with magnifications of 
1,000x, 2,000x, 5,000x, 10,000x and 20,000x were taken of each 
sample. Gel pore sizes were determined using ImageJ (v1.41o, 
NIH), using image analysis methods described previously in ref-
erence 4. Pore area data was statistically analyzed using ANOVA 
(α = 0.05) in Origin Pro 8.0.
To analyze the diffusivity of NGF in hydrogel matrices in 
FRAP studies, 2.5S NGF (Invitrogen, 13257-019) was labeled 
with fluorescein-5-isothiocyanate (FITC, Invitrogen, F-143) 
and purified in a Hi-Trap desalting column (GE Healthcare) 
on an Akta Purifer FPLC system (GE Healthcare). 100-μl gels 
of either 2% CS or HA containing either 0 or 76.9 nM EKR 
peptide, loaded with 100 μg/ml FITC-NGF, were prepared in 
8-well chamber slides. Procedures adapted from those previously 
described by Beier et al. were used for imaging and analysis.14 
Briefly, the fluorescent samples were viewed with a FluoView 
1000 confocal system connected to a TE2000 inverted micro-
scope (Olympus). An area of approximate uniform fluorescence 
Figure 11. representative phase contrast images of DrGs cultured in 
control ha hydrogels in the final culture study (scale bar = 0.25 mm). 
arcs denote the approximate neurite length in each image (a) ha con-
trol, 1 d; (B) ha control, 2 d; (C) ha control, 3 d.
Figure 12. Neurite lengths in final DrG study. Error bars ± standard er-
ror of the mean; n = 12 for CS,100:1 EKr:NGF, 9 for CS control, and 13 for 
ha control (*p ≤ 0.05 for CS,100:1 EKr:NGF vs. other treatments).
Peptides used in these studies were synthesized manually on 
Knorr resin (Synbiosci, SRK001) using standard FMOC chem-
istry in a specialized syringe filter system. Amino acids were 
coupled to the resin first using diisopropylcarbodiimide chem-
istry, followed by a second coupling step using o-(benzotriazol-
1-yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate 
(Synbiosci, REAG2) and lutidine (Sigma-Aldrich, L3900). 
Cleavage from the resin was accomplished using a cocktail of 
trifluoroacetic acid (Acros Organics, 139725000) containing 
2.5% water, 1.25% triisopropylsilane (TCI America, T1533), 
and 1.25% 1,2-ethanedithiol (Alfa Aesar, L12865) as scavengers. 
The cleaved peptide was precipitated in a 10x volume excess of 
cold ethyl ether (Mallinckrodt Chemicals, 0848-10), recovered 
by centrifugation, and then resolubilized in a solution of acetoni-
trile (Sigma-Aldrich, 34998) and water.
Peptide samples were purified using reverse-phase chromatog-
raphy utilizing a 22/250 Protein and Peptide C18 column (Grace-
Davidson) on an ÄKTA Explorer system (GE Healthcare). Purity 
of samples was confirmed using matrix-assisted laser desorption/
ionization time-of-flight (MALDI TOF) spectroscopy on a 4800 
Plus MALDI TOF/TOF Analyzer (Applied Biosystems).
To allow covalent coupling of the peptide to the hydrogel 
matrix, the EKR peptide was synthesized with a c-terminal cyste-
ine residue and a glycine spacer, to yield a final sequence of EKR 
IWF PYR RFG C. The thiol group on the terminal cysteine can 
bind with PEG-DA via Michael-type addition.13 To facilitate this 
reaction, a solution of PEG-DA (Sunbio Systems, Inc., P2AC-3) 
and thiolated EKR was adjusted to a pH between 7.5 and 8, and 
incubated at 37°C for 30 min. After this reaction, thiolated CS 
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the best-fit model. Assumptions applied to the model include: (1) 
Diffusion only occurs in the radial direction of ROIs, (2) bleach-
ing is an irreversible process that does not alter the structure of 
the gels and (3) Fickian diffusion is the only significant mode of 
mass transport.
Whole E8 chick DRGs were cultured in 2% CS or HA hydro-
gels using methods and reagents described previously in refer-
ence 5. To determine the effect of addition of the EKR peptide 
on DRG growth, 2% CS or 2% HA gels were created containing 
thiolated EKR peptide in either 1:1, 1:10, or 1:100 molar excess 
of NGF, which correspond to 76.9, 7.69 or 0.769 nM peptide, 
respectively. To covalently bind the peptide to the matrix, a media 
solution of peptide was combined with PEG-DA and incubated 
at 37°C for approximately one hour before use. Control gels con-
tained NGF only, and no peptide. 300 μl of media containing no 
NGF were added on top of each of the gels to prevent hydrogel 
desiccation and to allow NGF to diffuse out of the gels over time. 
Phase contrast images of DRGs were taken each day until growth 
was no longer observed, as determined by breakdown in neurite 
structure under 10x magnification. Calculation of average neu-
rite lengths for each image was executed as previously described 
in reference 4. Statistical analysis of neurite lengths was accom-
plished by ANOVA (α = 0.05) using Origin Pro 8.0.
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was located by scanning the gels with a 488-nm laser using an 
intensity of 5% and a 60x objective. Once a suitable area was 
found, a circle 20-μm in diameter at the center of the area was 
bleached using 100% laser intensity. After bleaching, the fluores-
cent responses in 19 concentric circles with radii ranging from 
3.93 to 76.18 μm were measured over time in 30 sec intervals 
using 5% laser intensity.
The average pixel intensity of each concentric circle, or region 
of interest (ROI), at various time points was normalized using 
the expression defined by Axelrod et al.:
such that the average intensity within the bleached ROI ranged 
between 0 and 1. In this equation, I(t,r
i
)
Normalized
 is the normal-
ized average intensity of the ith ROI at time t, I(t,r
i
) is the average 
true intensity of the ith ROI at time t, I(t
0
,r
0
) is the intensity of 
the center of the bleached area of the sample at time 0 (defined as 
the time of bleaching), and I(t,r
∞
) is the intensity of the infinite 
reservoir diffusing into the bleached area at time t.
Using the initial fluorescent intensity conditions from each 
of the experimental data sets, transient diffusion models were 
developed for each sample in COMSOL Multiphysics simulation 
software (COMSOL, Inc.). For a given hydrogel treatment, the 
initial intensities in each of the ROIs were averaged and used 
as the initial condition for the COMSOL model. Different dif-
fusion coefficients were applied to the models, and the result-
ing intensity profiles over each ROI were simulated as a function 
of time. For each diffusion coefficient, the model’s simulated 
intensity profile was compared with the experimental data, and 
the model exhibiting the smallest sum of squared differences 
between the experimental and model data was determined to be 
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